Latest News for: argent

Edit

Argent Biopharma Expands Pipeline With Promising Drug Cimetra®

MENA FN 17 Mar 2025
(MENAFN - PR Newswire) PERTH, Australia, March 16, 2025 /PRNewswire/ -- Argent BioPharma Ltd. (ASX. RGT) (OTCQB. RGTLF ), a clinical-stage biopharmaceutical company addressing unmet medical needs by ... .
Edit

Argent BioPharma Expands Pipeline with Promising Drug CimetrA® (Argent Biopharma Ltd)

Public Technologies 16 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

CimetrA Phase IIb Clinical Trial Results (Argent Biopharma Ltd)

Public Technologies 16 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

Exclusive Agreement for Malta Manufacturing Facility (Argent Biopharma Ltd)

Public Technologies 11 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

Notice of General Meeting/Proxy Form (Argent Biopharma Ltd)

Public Technologies 10 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

Strategic Manufacturing Partnership with ECCPharm Limited (Argent Biopharma Ltd)

Public Technologies 05 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

Appointment of Non-Executive Director (Argent Biopharma Ltd)

Public Technologies 04 Mar 2025
). The text version of this document is not available ... Argent Biopharma Ltd.
Edit

Initial Director's Interest Notice (Argent Biopharma Ltd)

Public Technologies 04 Mar 2025
Information and documents given to ASX become ASX's property and may be made public. Introduced 30/9/2001. [...] ... Argent Biopharma Ltd.
  • 1
×